Institute of Biomedical Research 

$0.001500
1
-$0.00-6.25%Friday 17:22

Statistics

Day High
0.0013
Day Low
0.0013
52W High
0.0102
52W Low
0.00094
Volume
993,455
Avg. Volume
1,435,144
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Jun 30Expected
Q3 2013
Q4 2013
Q1 2014
Q2 2014
Q3 2014
Q4 2014
Q1 2015
-0
0
0
0
Expected EPS
N/A
Actual EPS
0.0002

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments. MRES also focuses on the creation of novel biomedical and food products. A significant part of its mandate involves regulatory oversight of industrial activities and their associated products, alongside scientific environmental monitoring. Furthermore, it delivers expert regulatory evaluation and certification services for a wide array of biomedical products. The institute also contributes to academic advancement through graduate research study programs in the biomedical and environmental fields. MRES manufactures and supplies a diverse range of healthcare devices. Its offerings include two-channel analog NMS units, various digital muscle stimulators, digital TENS devices, interferential therapy units, elite combination models, portable four-channel digital stimulators, and portable ultrasound equipment. The product portfolio also extends to photon red light devices for aesthetic applications, electric pain relief solutions, microcurrent electrical nerve stimulators, and high-volt pulsed stimulators. The company excels in the development and commercialization of specialized agents and products. This category features microbicidal agents, a variety of disinfectant solutions, and specialized medical supplies such as bandages tailored for severe burns. They also provide products for hard surface disinfection, microbicidal treatments for fabrics and textiles, insecticides (including those targeting bed bugs), microbicidal towels, and mouthwash. Key innovations include Purilair, an apparatus specifically designed for sterilizing compressed air within medical instruments, alongside colloidal silver and other electro-medical devices. A notable product is BioStim INF, which is engineered for reducing edema, alleviating pain, and delivering comprehensive therapeutic benefits. Beyond its product and research endeavors, MRES offers a broad spectrum of essential services. These include quality control, regulatory assistance, healthcare support, environmental analysis, building decontamination, and extensive environmental protection and management services. They are also a critical source for regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was established in 2010 and maintains its headquarters in Podgorica, Montenegro, with a representative office located in Montreal, Canada, facilitating its global operations.
Show More
CEO
Drasko D. Pekovic
Employees
5
Country
Other
ISIN
US45781A1079

Listings

0 Comments

Share your thoughts

FAQs

What is Institute of Biomedical Research stock price today?▼
The current price of MRES is $0.00 USD — it has decreased by -6.25% in the past 24 hours. Watch Institute of Biomedical Research stock price performance more closely on the chart.
What is Institute of Biomedical Research stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Institute of Biomedical Research stocks are traded under the ticker MRES.
Is Institute of Biomedical Research stock price growing?▼
MRES stock has fallen by -0% compared to the previous week, the month change is a -14.29% fall, over the last year Institute of Biomedical Research has showed a -81.01% decrease.
What were Institute of Biomedical Research earnings last quarter?▼
MRES earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Institute of Biomedical Research have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Institute of Biomedical Research located?▼
Institute of Biomedical Research operates in the Health & Wellness sector.
When did Institute of Biomedical Research complete a stock split?▼
The last stock split for Institute of Biomedical Research was on April 28, 2014 with a ratio of 1:10.
Where is Institute of Biomedical Research headquartered?▼
Institute of Biomedical Research is headquartered in Podgorica, Other.